Soft Tissue Sarcoma


Soft tissue sarcoma characteristic feature-  Recurrence, recurrence, recurrence.
Reason for recurrence- 1. Technical 2. The way these tumour exists {false capsule, pseudopods of tumour, infiltration of surrounding tissues}
Very different type of staging system
Grade is also included in classification- GTNM system of classification. 

Site specific distribution:-
site
Percentage (%)
Head and neck
11
Trunk
10
Retroperitoneum+intraabdominal
14
Visceral
15
Upper extremities
15
Lower extremities
35


Pattern of growth:-
·         Most grow in expansile manner
·         Flattening the normal tissues around them in concentric manner to form compression and reactive zone:::   pseudocapsule
·         Extension sprouting small tentacles perforating the pseudocapsule
·         Small finger like extensions grow to form clinical occult deposits at a variable distance from the parent lesions
·         Continued growth=> multinodular mass configuration of large, high grade deeply situated sarcomas
·         “Barriers”



Skin:-
·         Angiosarcoma/ Lymphangiosarcoma
·         Kaposi’s sarcoma
·         Epitheloid sarcoma
·         Dermatofibrosarcoma protuberans (on trunk)



Angiosarcoma/ (Blood Lymph vessels tumours)
·         Haemangiosarcoma
o   Elderly
o   Aggressive, arises in head and neck, breast, liver
o   Specially affects the skin and superficial soft tissues (most STS are deep)
o   Differentiation from haemangioma difficult
o   5 years survival rate <20%
·         Haemangio-pericytoma
o   Originates in blood vessels
o   Affects all ages
o   Develops in the tips (Glomus tumour)
o   Lower extremity/ pelvis
o   Commoner in females
o   5 year survival rate about 50%
·         Lymphangiosarcoma
o   Older patients
o   Aggressive
o   Arises in chronic lymphatic stasis( specially post mastectomy)
o   5 year survival rate 10%




Dermatofibrosarcoma Protuberans –
·         Rare
·         Develops in the skin of trunk/ extremities
·         Almost never metastasizes
·         10% poorly differentiated (high grade)
·         Survival related to tumour grade


Kaposi’s sarcoma-
·         Tissue of origin not clearly known
·         Older patients
·         Extremely indolent lesion
·         Lower extremity (Mediterranaen Jews)
·         The epidemic and aggressive variety is associated with AIDS and in bantu tribes


Epitheloid Sarcoma:-
·         Rare and tissue of origin unkown, young adults.
·         Aggressive, typically appears on distal extremities.
·         Amongst the most common tumours of the hand and foot.
·         Spreads to non-contiguous areas of skin, subcutaneous tissue, fat, draining lymph nodes and the bone [differentiates it from other STS]
·         5 year survival rate 30%
  





Head & Neck
·         Rhabdomyosarcoma
·         Angiosarcoma (elderly)
·         Osteogenic sarcoma (jaw)



Rhabdomyosarcoma:-
·         Tissue of origin: Striated muscle
·         In G-TNM staging all are grade – III
·         All types in any age group
·         Embroynal: [ teenagers, head and neck(70%), genitalia ]
·         Pleomorphic: [>30 years, rare, develops in extremities, highly anaplastic]



Distal Extremity:-
·         Epithelial sarcoma
·         Synovial sarcoma
·         Clear cell sarcoma
·         Osteogenic sarcoma (femur)



Clear cell sarcoma:-


·         Rare & tissue of origin unknown
·         Now recognised as a form of malignant melanoma
·         Adults<40 years
·         Painless, firm, spherical masses on tendon sheaths & aponeurotic structures of distal extremities, head and neck
·         5 year survival rate is about 50%
 


Extremities:
·         Liposarcomas
·         Malignant fibrous histocytoma
·         Tendosynovial sarcoma
·         Fibrosarcoma


Liposarcoma:-   

·         Arises from fat tissue
·         15-18%
·         Middle aged and older men
·         Thigh, groin, buttocks, shoulder, retroperitoneum
·         Does not arise from benign lipomas!!
·         5 year survival rate is 80% for low grade, 20% for high grade liposarcomas

Fibrosarcomas:
·         Tissue of origin: fibrous tissue
·         Incidence 5-10%
·         Affects all age groups
·         Arises in mesenchymal tissue
·         Usually involves abdominal wall and extremities
·         90% well differentiated (desmoid)

  

Malignant Fibrous Histiocytoma (MFH):-
·         Tissue of origin – fibrous tissue and histiocyte
·         Incidence – 10 – 23%
·         Age>40 years
·         Most common STS in some series
·         Develops in extremities (specially legs), Retroperitoneum



Mesothelium/ Retroperitoneum/ Mesentery :-
·         Mesothelioma
·         Leiomyosarcoma
·         Liposarcoma
·         Malignant Fibrous Histiocytoma



Mesothelioma:-
·         Tissue of origin: Mesothelium
·         > 50 years
·         Asbestos exposure
·         Involves Pleura, Peritoneum
·         Highly lethal
·         5 year survival rate is <10%



Retroperitoneal Sarcomas:-
·         Liposarcomas
·         Leiomyosarcoma




Gastrointestinal tract:-
·         Gastrointestinal stromal tumours (GIST) do not express markers of myogenic differentiation.
·         Similar to leiomyosarcomas but different IHC staining
·         GIST do not stain for actin (leiomyosarcomas do!)
·         GIST express SC 117 (c-lat protein)
·         Gastrointestinal autonomic nerve tumours (GANT) exhibit neural differentiation
·         The pattern of recurrence is intra-abdominal including liver metastasis




Leiomyoma Peritonealis Disseminata (LPD)
·         Women in reproductive years
·         Asymptomatic, benign looking leiomyomas scattered throughout the peritoneal cavity ranging from 1-10cm in size
·         Stimulated by estrogen
·         LPD causes occasional mechanical problems with bowel or pain
·         No treatment except estrogen or anti-estrogen drugs required




Chest wall:
·         Desmoids
·         Liposarcomas
·         Myogenic sarcomas




Neurofibrosarcoma [MPNST, Schwannoma]:
·         Origin: nerve sheaths (thickening nerves, without autonomic predilection)
·         Young and middle aged
·         Patients with von Recklinghausen’s disease (10% develop sarcomatous changes in life)
·         Histologically resemble fibrosarcoma
·         Presents with superficial variety: low grade, spreads extensively along nerve sheaths without metastasizng, survival rate >90%
·         Penetrating variety: nodular growth, vascular invasion/lung metastasis- 5 year survival <20%




Synovial sarcoma:
·         Originates from tenosynovial mesothelium
·         Young adults 2nd to 4th decade
·         Hard masses near tendons and painful
·         Synovial and epitheloid sarcomas are the most common tumours of hands, knee and feet
·         G-TNM stage: all are grade III
·         High rate of local recurrence


History-
·         30 yrs old male, low socioeconomic
·         Swelling over right thigh- 3 months
·         Patient initially noticed a 2*2 cm swelling in the Rt thigh 2 years back; gradual increase in size
·         Not associated with pain, weakness in the Rt lower limb, ulceration or any other swelling in the Rt groin.
·         H/O surgery for the swelling one and a half years back; swelling recurred within 6 months of surgery.
·         Another surgery done 4 months back; recurrence within a month of the surgery.
·         Since then the swelling has increased rapidly in size
·         No H/O wt loss or loss of appetite
·         No H/O headaches, seizures, bone pains, cough, hemoptysis, jaundice.
·         No H/O Tb/DM/ HTN or any other co-morbid condition
·         Family History – non contributory
·         Personal History – non contributory

Examination:


·         Vitals – stable
·         Performance status – 90% Karnofsky
·         Nutritional status – poor
·         Hydration status – adequate
·         Lt Lower Limb – within normal limit
·         Rt Lower limb – extended at hip and knee
·         Scar mark of previous surgery seen
·         No ulceration, no pigmentation
·         8*6 cm mass in the lateral aspect of the thigh
·         No local rise of temperature
·         Fixed to skin
·         Nontender, irregular surface and margins
·         Variegated consistency
·         Fixed to the underlying muscles
·         No neuro-vascular deficit in the Rt LL
·         No enlarged inguinal LN present

Limb examination (important point):-
·         Attitude of extension or external rotation
·         Movements of the hip

Investigation:-
·         Core biopsy – exact histopathology and grade of tumour
·         FNAC – it does not tell about grade of tumour, not very popular in soft tissue sarcoma.















Short Bowel Syndrome


Short Bowel Syndrome
-          Type of intestinal failure
-          Intestinal failure – inadequate digestion and absorption of nutrients
Main factors
-          Loss of absorptive surface
-          Rapid transit

Prevalence-
-          3-4 million
-          15% of all intestinal resections
-          In 3/4th massive resection
-          In 1/4th recurrent resection

Intestinal length-
-          300 – 600 cm normal
-          Resection of half of it is well tolerated
-          SBS may develop if remnant <180cm
-          PN can be weaned off if-
o   120 cm without colon
o   60 cm with colon continuity

Intestinal Length
Need for Parenteral Nutrition
>180 cm
none
120-180 cm or 90 – 120 cm with colon
< 6 month
60 – 90 cm with colon
6 - 12 month
< 60 cm small intestine
permanent

-          Outcome not dependent entirely on length
-          It also depends on-
o   Location
o   Function
o   Status of other digestive organs
o   Ileo-caecal valves
o   Adaptive capacity


Reason for Ileal remnant doing better than jejunal remnant:-
-          Special absorptive property for bile salts and Vitamin B12
-          Hormone secretion
-          More adaptation
-          Presence of ileocaecal junction improves the functional capacity


Other digestive organs:-
-          Stomach
-          Pancreatic secretions
-          Colon
-          Jejunocolic anastomosis (Type II anastomosis) is equivalent to 30cm of additional small bowel.
-          Jejunoileocolic anastomosis (Type III) is equivalent to additional 60 cm
-          End jejunostomy (Type I anatomy) 100 cm of remnant is required to avoid permanent PN.


Intestinal adaptation-
-          Stimulated by exposure of the residual mucosa to macronutrients
-          Remaining bowel increases in length and diameter
-          Hyperplasia of small intestinal mucosa with increased number and size of crypts and villi
-          Develops over 1-2 years
-          Neurohormonal mediators-
o   Glucagon like peptide 1 and 2(GLP – 1 and GLP – 2), peptide YY(PYY) and neurotensin

Long term outcome-
-          Age
-          Underlying disease
-          Complications of management

Causes of Short Bowel Syndrome-
-          Surgery  25%
-          Radiation    24%
-          Mesenteric vascular disease   22%
-          Crohn’s   16%
-          Others   13%


Complications (SBS)
General
Specific
Malnutrition and weight loss
Cholelithiasis
Diarrhoea & Steatorrhea
Gastric hypersecretion
Vitamin and mineral deficiency
Nephrolithiasis
Fluid and electrolyte imbalance
Liver disease


Management:-
-          Control sepsis
-          Fluid and electrolytes
-          Nutrition
-          Maximise the function of remaining intestine
-          Prevent complications of underlying disease and nutritional therapy


Acute phase (1 to 4 weeks) -
-           RL, amino acids, Glucose, water soluble vitamins, trace elements
-          3rd day TPN
-          5th day enteral feed –
o   Iso-osmolar salt glucose solutions
o   MCT
o   Amino acids

Adaptation phase (1 week to 2 years)-
-          Oral intake gradually increased to 30 – 40 kcal/kg/day
-          Slowing of intestinal motility – Loperamide or codeine
-          Suppression of gastric acid output PPI
-          Trace elements and vitamins


Maintenance phase-
-          Target absorption rate of 30 -40 kcal/kg/day (ideal body weight)
-          About 45 – 60 kcal/kg/day must be ingested
-          Regular supplementation of viatmins, minerals and trace elements
-          Calcium should be given generously by mouth (800-1200mg/day)


Vitamins-
Vitamin                A                            10,000-50,000/day
Vitamin B12                        300microgram/day
Vitamin C                             200 – 500 mg/day
Vitamin D                            1600 microgram/day
Selenium                             60 – 100 microgram/ day
Zinc                                        220 – 440 mg/ day



Nutrition-
-          Enteral nutrition as soon as possible
-          It helps in ADAPTATION
-          Optimal diet is controversial
-          Simple nutrients and partially hydrolysed diets
-          Concentrated sugars like fruit juices should be avoided – they generate high osmotic load.


End ileostomy :   no fat restriction (30 – 40% energy)
Fat requirements as MCT (low digestion requirements)
With colon :  20 – 30% of calorie from fats

Drugs to inhibit intestinal secretions-
-          H2 receptor antagonist
-          Somatostatin
-          Cholylsarcosine – synthetic bile acid improves fat absorption without causing diarrhoea

Complication Prevention
Metabolic
TPN related
Hypomagnesemia
Catheter sepsis
Hypocalcemia
Liver disease
Vitamin D deficiency
Bacterial overgrowth
Iron
Cholelithiasis
Selenium, Zinc, Copper
Nephrolithiasis


Preventing early liver failure-
-          Avoid sepsis
-          Enteral nutrition
-          Mixed Fuel (<30% energy from fats)
-          UDCA

Non Transplant Surgical Option-
-          Restore intestinal continuity
-          Continued malabsorption (despite medical therapy)
-           Need for specialized nutritional support
-          Intestinal complications (obstruction and fistulas)


Ostomy closure:    (possible in 1/4th to 1/2)
-          Increase absorption
-          Prolongs transit time
-          Jejunocolic anastomosis is functionally equivalent to adding 30 cm of small bowel
-          If small bowel remnant is less than 60 cm problems of diarrhoea and perianal complications


Obstruction and Fistulas:
-          Stricturoplasty- (Heinke-mikulicz type)
-          Serosal patch for fistula

Tapering procedures:
-          Dilated segments (Crohn’s diseases)
-          Aim to improve motility
-          It means reduction of circumference of intestine by imbrication or excision of redundant part along the antimesenteric border.



To Decrease the transit time-
-          Artificial valves created by distal intussusception of a segment of small intestine.
-           Ten-centimetre reversed segments

Binachi’s lengthening technique
STEP – Serial Transverse Enteroplasty Procedure


Criteria for clinical improvement:
-          Reducing (>25%) or discontinuing PN requirements while maintaining bodyweight
-          Resolving a specific anatomical problem (eg obstruction or fistula)
-          Ameliorating symptoms of malabsorption (eg.diarrhoea or metabolic abnormalities such as hypocalcemia.

Intestinal transplant:
-          Mortality rate of patients on PN for benign disease 5-25%/yr
-          15% at 3 years
-          Greatest for infants